US2018002733A1PendingUtilityA1
Methods for increasing mannose content of recombinant proteins
Est. expiryMar 14, 2033(~6.6 yrs left)· nominal 20-yr term from priority
Inventors:Jian WuSean DavernSimina Crina PetrovanMichael Charles BrandensteinKatherine Rose LindahlShawn Erik Lillie
C07K 2317/14C12N 2500/32C07K 2317/41C12P 21/005C12N 5/0037C12N 2500/34C07K 16/00C12N 1/38C12N 2510/02
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to methods of modulating the mannose content of recombinant proteins.
Claims
exact text as granted — not AI-modified1 . A method for modulating mannose 5 on a recombinant protein during a mammalian cell culture process comprising limiting the amount of glucose in the cell culture medium, wherein the concentration of the glucose is from about 0 to 6 g/L, and supplementing the cell culture medium with galactose or sucrose, wherein the concentration of galactose is from 6-13 g/L or the concentration of sucrose is from about 16-24 g/L.
2 . The method according to claim 1 , wherein the glucose concentration in the cell culture medium is sufficient to result in a concentration of glucose in the spent medium at about 0 g/L.
3 . (canceled)
4 . A method according the claim 1 , wherein the concentration of glucose in the cell culture medium is from 4 to 6 g/L.
5 . The method according to claim 1 , wherein the concentration of glucose in the cell culture medium is from 1 to 3 g/L.
6 . The method according to claim 1 , wherein the concentration of glucose in the cell culture medium is from 2 to 3 g/L.
7 . The method according the claim 1 , wherein the concentration of glucose in the cell culture medium is 2.5 g/L.
8 . The method according the claim 1 , wherein the concentration of glucose in the cell culture medium is 0 g/L.
9 . (canceled)
10 . The method according to claim 1 , wherein the concentration of galactose is from 10 to 13 g/L.
11 . The method according to claim 1 , wherein the concentration of galactose in the cell culture medium is from 10 to 12 g/L.
12 . The method according to claim 1 , wherein the concentration of galactose in the cell culture medium is 11.5 g/L.
13 . (canceled)
14 . (canceled)
15 . The method according to claim 1 , wherein the limiting amount of glucose is added during a production phase.
16 . (canceled)
17 . The method according the claim 1 , wherein the cell culture process is a perfusion process.
18 .- 63 . (canceled)
64 . The method according to claim 1 , wherein the mammalian cells are Chinese Hamster Ovary (CHO) cells.
65 . The method of claim 1 , wherein the recombinant protein is selected from the group consisting of a human antibody, a humanized antibody, a chimeric antibody, a recombinant fusion protein, or a cytokine.
66 . The method according to claim 1 , further comprising a step of harvesting the recombinant protein produced by the cell culture.
67 . The method of claim 1 , wherein the recombinant protein produced by the cell culture is purified and formulated in a pharmaceutically acceptable formulation.
68 . The method of claim 1 , wherein recombinant protein production in the high mannose glycan species are increased compared to a culture where the cells are not subjected to limited glucose in combination with galactose.Join the waitlist — get patent alerts
Track US2018002733A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.